Key Insights

Highlights

Success Rate

93% trial completion (above average)

Published Results

497 trials with published results (27%)

Research Maturity

1414 completed trials (77% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

5.4%

99 terminated out of 1833 trials

Success Rate

93.5%

+7.0% vs benchmark

Late-Stage Pipeline

33%

606 trials in Phase 3/4

Results Transparency

35%

497 of 1414 completed with results

Key Signals

497 with results93% success99 terminated

Data Visualizations

Phase Distribution

1,606Total
Not Applicable (492)
Early P 1 (15)
P 1 (279)
P 2 (214)
P 3 (330)
P 4 (276)

Trial Status

Completed1,414
Unknown206
Terminated99
Recruiting40
Withdrawn24
Not Yet Recruiting22

Trial Success Rate

93.5%

Benchmark: 86.5%

Based on 1414 completed trials

Clinical Trials (1833)

Showing 20 of 20 trials
NCT07569744Not ApplicableNot Yet RecruitingPrimary

Resveratrol for Endothelial Dysfunction and Metabolic Control in Type 2 Diabetes

NCT07099482Not ApplicableNot Yet Recruiting

"Ultrasound-Enhanced Propolis Therapy for Healing Diabetic Foot Wounds"

NCT07276776Not ApplicableCompletedPrimary

An Evaluation of the Omnipod® M System in Adults With Type 2 Diabetes

NCT07560800Not ApplicableNot Yet RecruitingPrimary

Effect of Beetroot Juice on Cardiovascular and Autonomic Responses to Exercise in Adults With Type 2 Diabetes

NCT07433192RecruitingPrimary

POLUS: Description of the Effectiveness and Tolerability of Luseogliflozin in Patients With Type 2 Diabetes.

NCT06422039Phase 1CompletedPrimary

Bioavailability and Food Effects of HRS-7535 Tablets With Different Formulating Processes in Healthy Subjects

NCT03887936Phase 4CompletedPrimary

Testosterone Therapy and Bone Quality in Men With Diabetes and Hypogonadism

NCT05881447Recruiting

Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa

NCT07554469Not Yet Recruiting

An Observational Study, Called FINEXPLORER, to Learn More About How Well Finerenone Works in Adults in Spain With Chronic Kidney Disease (CKD) Linked to Type 2 Diabetes, by Looking at Changes in a CKD Risk Score

NCT07351058Phase 3Recruiting

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

NCT06495931Phase 1CompletedPrimary

Study on Drug Interaction of HRS-1780 Tablets, Henagliflozin Tablets, Metformin Tablets and HRS-7535 Tablets in Healthy Human

NCT07433062Phase 1SuspendedPrimary

A Study to Evaluate the Effect of AZD6793 on the Pharmacokinetics and Pharmacodynamics of Metformin in Participants With Type 2 Diabetes Mellitus

NCT07541456Phase 4CompletedPrimary

Empagliflozin Versus Non-SGLT2 Oral Drugs for Blood Pressure in Type 2 Diabetes

NCT05933161RecruitingPrimary

A Study of Glycemic Control in Left Ventricular Assist

NCT07538505Not ApplicableNot Yet RecruitingPrimary

Testing a Diabetes Care Program in Rural and Low-Income Clinics

NCT07232537Recruiting

An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and Type 2 Diabetes in a Routine Medical Care Setting in South Korea

NCT06704672Not ApplicableRecruiting

Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes Mellitus

NCT05067621Phase 2Active Not RecruitingPrimary

Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease

NCT07124039Completed

An Observational Study Called FIRST-2.0 China to Learn More About the Use of the Study Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions in a Chinese Population.

NCT07521475Not ApplicableNot Yet RecruitingPrimary

Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes

Scroll to load more

Research Network

Activity Timeline